Intersouth Partners Promotes Burt, Rosen To Partner

Dow Jones VentureWire

Intersouth Partners Promotes Burt, Rosen To Partner

Intersouth Partners has expanded its team to 12 partners with the promotion of two associates, Katrin Burt and James Rosen.

The promotions were part of a normal career path progression at the firm, Founding Partner Dennis Dougherty said. Burt and Rosen had both served as associates since 2007. As partners, the two will lead deals for the life science and technology teams and serve on company boards.

Burt joined Intersouth as an analyst in 2004 and was subsequently promoted as an associate for the technology team. As partner she will work to source potential technology, materials and alternative energy deals. She currently works with portfolio companies including Bright Hub Inc., HexaTech Inc., siXis Inc. and Ziptronix Inc.

Prior to Intersouth, Burt was a foreign exchange trader at HSBC Holdings PLC.

Rosen joined Intersouth in 2005 as an investment intern while in graduate school. As partner he will source deals for the life science team, focusing on areas including medical devices and medical technology. Rosen carried out a large part of the work on Intersouth’s recent lead investment in ABT Molecular Imaging Inc., which was announced earlier this month, Dougherty said.

In addition to ABT, Rosen also works with Applied Genetic Technologies Corp., Cempra Pharmaceuticals Inc. and Viamet Pharmaceuticals Inc. He previously held positions at UNC Lineberger Comprehensive Cancer Center and as an equity research analyst at Brean Murray & Co.

Intersouth continues to work from its $275 million seventh fund, Intersouth Partners VII, which closed in 2006, Dougherty said. The firm has about one year of investing left to do, he said, for a potential total of seven to eight new investments. The firm has made 16 investments from that fund so far, with about 60% in life sciences and 40% in technology.

Based in Durham, N.C., Intersouth mostly focuses on investments in the Southeast.